Table 65.
Patent grant information of the thiazolidinedione analogues.
| S. No. | Patent No. | Title | Procedure/Activity | Reference |
|---|---|---|---|---|
| 1 | WO/2019/016826 | Novel 5-[4-(2-biphenyl-4-yl-2-oxo-ethoxy)-benzylidene]-thiazolidine-2,4-diones, their synthesis, and uses thereof. | Antidiabetic activity | [93] |
| 2 | WO/2002/026735 | Sodium salts of 5-’4-’2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione. | Synthetic procedure | [94] |
| 3 | WO/2006/010345 | Salt of oxalic acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)-amino)ethoxy]benzyl]thiazolidin -2,4-dione and a method of its preparation and its use. | Antidiabetic activity | [95] |
| 4 | US 6,784,184 B2 | 5-(arylsulfonyl)-,5-(arylsulfinyl) and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for the inhibition of farnesyl-protein transferase. | Anticancer activity | [96] |
| 5 | WO/2003/053962 | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2, 4-dione malic acid salt and its use against diabetes mellitus. | Antidiabetic activity | [97] |
| 6 | US 2020/0093812 A1 | 5-[[4-[2-[5-(1-Hydroxyethyl)pyridin-2-yl] ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione for treating nonalcoholic fatty liver disease. | Treatment of non-alcoholic fatty liver disease | [98] |
| 7 | EP0508740A1 | Thiazolidinedione derivatives, their production, and their use. | Hypoglycemic and hypolipidemic activity | [99] |
| 8 | WO03053367A2 | Hydrogenation of precursors to thiazolidinedione antihyperglycemics. | Anti-hyperglycemic activity | [100] |
| 9 | CN101531657A | Dimethyldiguanide of the thiazolidinedione pharmaceutical, preparation method and use thereof. | Anti-diabetic activity | [101] |
| 10 | CN104230915A | Thiazolidinedione-containing phenylpiperazine derivatives, as well as the preparation method and applications of thiazolidinedione-containing phenylpiperazine derivatives. | Anti-cancer activity | [102] |
| 11 | WO2010077101A2 | Novel thiazolidinedione derivative and use thereof. | Treatment of CVS, renal disease, and GIT disease | [103] |
| 12 | JP2002322177A | Thiazolidinedione derivative. | Anticancer activity | [104] |
| 13 | WO2007109037A2 | Thiazolidinedione analogues. | Antihypertensive activity | [105] |
| 14 | WO2017021634A1 | Association between 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl] methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione and a tyrosine kinase inhibitor of the EGFR. | Anticancer activity | [106] |